Evolving drug regulatory landscape in China: A clinical pharmacology perspective

MLA

Weifeng Tang, et al. “Evolving Drug Regulatory Landscape in China: A Clinical Pharmacology Perspective.” Clinical and Translational Science, vol. 14, no. 4, July 2021, pp. 1222–30. EBSCOhost, https://doi.org/10.1111/cts.12987.

APA

Weifeng Tang, Ying Huang, Diansong Zhou, Yao Huang, Yingxue Chen, Song Ren, Yan Li, Shengqian Wu, Xiaoying Zhao, Xuyang Song, Haidong Wang, Yuwen Jin, Hongtao Yu, Li Zhang, Yunfei Li, David Boulton, & Kevin Shen. (2021). Evolving drug regulatory landscape in China: A clinical pharmacology perspective. Clinical and Translational Science, 14(4), 1222–1230. https://doi.org/10.1111/cts.12987

Chicago

Weifeng Tang, Ying Huang, Diansong Zhou, Yao Huang, Yingxue Chen, Song Ren, Yan Li, et al. 2021. “Evolving Drug Regulatory Landscape in China: A Clinical Pharmacology Perspective.” Clinical and Translational Science 14 (4): 1222–30. doi:10.1111/cts.12987.